Analysis of Volatile Organic Compounds by Electronic Noses in Hospitalised Patients for an Infection by SARS-COV-2 (COVID-19) (VOC-COVID)

Hopital Foch

Status: Completed

Conditions: COVID-19

Treatments: Device: Volatile Organic Compounds analysis

Study type: Interventional

Funder types: Other

Identifiers

NCT04379154

2020_0060

Details and patient eligibility

About

The study of volatile organic compounds (VOCs) detected in exhaled air is an innovative research area for respiratory diseases. This analysis can be done by the technique of electronic nose, simpler and faster, which provides an idea of the general profile of the VOCs without identifying them. The VOCs in exhaled air in patients hospitalized for COVID-19 infection are analysed in this study, using electronic noses.

Enrollment: 65 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients infected by SARS-CoV-2 whose medical condition warrants hospitalisation (out of intensive care) for oxygen therapy less or equal to 4 l/min
• Patients must be 18 years of age or older
• Fluent in the French language
• Have signed a consent form
• Being affiliated with healthcare insurance

Exclusion criteria

• Pregnant woman
• Patient deprived of liberty by judicial or administrative decision

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

65 participants in 1 patient group

Volatile Organic Compounds analysis

Experimental group

Description:

Volatile Organic Compounds analysis in exhaled air in patients hospitalised for COVID-19 infection

Treatment:

Device: Volatile Organic Compounds analysis